Medica Sur SA de CV (MEDICAB) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor long term growth as Operating profit has grown by an annual rate 3.90% of over the last 5 years

Flat results in Jun 25

With ROE of 21.71%, it has a fair valuation with a 2.39 Price to Book Value

Market Beating performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

MXN 6,153 Million (Micro Cap)

P/E

11.00

Industry P/E

Dividend Yield

0.02%

Debt Equity

-0.22

Return on Equity

20.95%

Price to Book

2.40

Revenue and Profits:

Net Sales:

1,181 Million

(Quarterly Results - Jun 2025)

Net Profit:

136 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

60.0%

6 Months

64.51%

1 Year

47.33%

2 Years

33.4%

3 Years

3.7%

4 Years

72.31%

5 Years

302.88%

Medica Sur SA de CV for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

3.70%

EBIT Growth (5y)

3.90%

EBIT to Interest (avg)

8.23

Debt to EBITDA (avg)

0.11

Net Debt to Equity (avg)

-0.12

Sales to Capital Employed (avg)

1.33

Tax Ratio

29.58%

Dividend Payout Ratio

28.43%

Pledged Shares

Institutional Holding

ROCE (avg)

25.99%

ROE (avg)

16.72%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.39

EV to EBIT

7.74

EV to EBITDA

6.04

EV to Capital Employed

2.61

EV to Sales

1.20

PEG Ratio

0.58

Dividend Yield

0.02%

ROCE (Latest)

33.76%

ROE (Latest)

21.71%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -1.96% vs 6.46% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -4.50% vs 5.41% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,181.30",
          "val2": "1,204.90",
          "chgp": "-1.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "247.90",
          "val2": "252.30",
          "chgp": "-1.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "19.10",
          "val2": "18.90",
          "chgp": "1.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "135.90",
          "val2": "142.30",
          "chgp": "-4.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "166.70%",
          "val2": "167.70%",
          "chgp": "-0.10%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.61% vs 6.77% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -24.27% vs 18.00% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,402.80",
          "val2": "4,129.80",
          "chgp": "6.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "882.30",
          "val2": "844.60",
          "chgp": "4.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "123.80",
          "val2": "119.60",
          "chgp": "3.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-74.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "422.50",
          "val2": "557.90",
          "chgp": "-24.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "156.30%",
          "val2": "161.30%",
          "chgp": "-0.50%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

1,181.30

1,204.90

-1.96%

Operating Profit (PBDIT) excl Other Income

247.90

252.30

-1.74%

Interest

19.10

18.90

1.06%

Exceptional Items

0.00

Consolidate Net Profit

135.90

142.30

-4.50%

Operating Profit Margin (Excl OI)

166.70%

167.70%

-0.10%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -1.96% vs 6.46% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -4.50% vs 5.41% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

4,402.80

4,129.80

6.61%

Operating Profit (PBDIT) excl Other Income

882.30

844.60

4.46%

Interest

123.80

119.60

3.51%

Exceptional Items

-74.40

0.00

Consolidate Net Profit

422.50

557.90

-24.27%

Operating Profit Margin (Excl OI)

156.30%

161.30%

-0.50%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 6.61% vs 6.77% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -24.27% vs 18.00% in Dec 2023

All Annual Results

Company CV

About Medica Sur SA de CV

Medica Sur SA de CV

Pharmaceuticals & Biotechnology

Medica Sur SAB de CV is a Mexico-based company primarily engaged in the healthcare sector. The Company manages hospitals, emergency and diagnostic centers, medical laboratories, organ and blood banks, as well as an accommodation place. It provides medical services within various specializations, such as anatomic pathology, cardiology, gynecology and obstetrics, neonatology, neurophysiology, odontology, oncology, ophthalmology, orthopedics, otolaryngology, pediatrics, radiology and imaging, as well as radiosurgery. In addition, the Company offers medical tourism services and distributes drugs. It forms a part of Mayo Clinic Care Network. The Company operates through a range of subsidiaries, such as Corporacion de Atencion Medica SA de CV, El Portal Medico SA de CV, Servicios de Administracion Hospitalaria SA de CV and Telemed SA de CV. The Company is owned by Neuco SA de CV.

Company Coordinates

Company Details

Puente de Piedra 150, Col. Toriello Guerra TLALPAN None : 14050

Tel: 52 55 5424720052 5 4247200

http://www.medicasur.com.mx

Registrar Details